KUALA LUMPUR, Jan 15 (Bernama) -- Henry Schein Inc. and Vets First Choice announced their 11-member board of directors for Covetrus with David E. Shaw as chairman and Philip A. Laskawy as lead independent director.
Covetrus is the new standalone public company that will result from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice. The merger is expected to be completed on or about Feb 4.
“Our intention has been to create a board that reflects the expansive and transformative nature of the Covetrus opportunity, and we believe that this slate of nominees achieves that in terms of calibre, diversity, independence and other qualities.
“This group has a strong mix of relevant experience, global domain knowledge and extensive capabilities across keyboard functions that will help Covetrus scale its technology-enabled services platform across the globe and deliver upon its mission of advancing the world of veterinary medicine,” said Shaw in a statement.
Another nine individuals are expected to be appointed to the Covetrus board of directors.
Henry Schein is a solutions company for healthcare professionals powered by a network of people and technology, while Vets First Choice is an innovator in technology-enabled services.
For more information, visit www.henryschein.com or www.vetsfirstchoice.com.
-- BERNAMA
No comments:
Post a Comment